Amarin Corp Plc (AMRN)

[speedrunner]

At this point. options are very limited. 3 options: 1) sell the company; 2) Partner for vascepa sales or for reduce it study or both;3)GIA and dilute the shares. I personally like option 2 the best. I still see a good probability of reduce it out come study. If this happens, I foresee a potential 10 billion dollar drug but this will not happen until possibly 2017 and there will be lot of pain in-between. After assessing all options, I am in for the long run.

With Marine indication alone, I see peak sales between 200-500 million by 2015- which should value the company at 1-2 billion market cap.